98974377

NHS Issues Important Guidance for Four Groups on Beclometasone Inhalers Used in Asthma Treatment

Beclometasone inhalers are a commonly prescribed treatment for asthma and certain respiratory conditions, functioning primarily as preventer medications to reduce airway inflammation and control symptoms. The NHS has issued important guidance highlighting that these inhalers, while effective for most patients, may not be appropriate for everyone.

Beclometasone works by calming the body’s immune response and reducing inflammation in the airways, which helps ease breathing difficulties. In addition to asthma, it is also prescribed for managing chronic obstructive pulmonary disease (COPD) under NHS recommendations.

Typically delivered through inhaler devices known as puffers—often brown, beige, red, or pink—beclometasone inhalers are designed for daily use to maintain symptom control. Most adults and children over the age of five can safely use these inhalers, but some brands are only suitable for older children.

READ MORE: Gloucester Council Faces Financial Crisis Amid Celebration Claims for 2025

READ MORE: Crewe Alexandra vs Cheltenham Town: How to Watch and TV Guide

The NHS highlights four specific groups of people who should exercise particular caution when using beclometasone inhalers. Patients are advised to inform their healthcare provider if they fall into any of these categories to ensure the treatment is safe for them.

It’s important to note that beclometasone inhalers do not provide immediate relief during an asthma attack characterized by coughing, wheezing, or breathlessness. However, some combined inhalers that include formoterol can serve both as preventers and relievers.

Common brand names for beclometasone inhalers include Fostair, Luforbec, and Bibecfo. Some formulations combine beclometasone with additional medications to enhance breathing support.

Daily use is crucial, even when symptoms are not present. NHS guidelines also stress the importance of rinsing the mouth or brushing teeth after using steroid inhalers to prevent infections and sore mouth.

For patients requiring high doses of beclometasone, they may receive a blue steroid treatment card or a steroid emergency card, which can be obtained through pharmacists or doctors. Along with preventer inhalers, patients are typically provided with a separate reliever inhaler to manage sudden symptoms.

By following NHS advice, patients can ensure they use beclometasone inhalers safely and effectively to manage their respiratory health.

SUBSCRIBE FOR UPDATES


No spam. Unsubscribe any time.